Allevi (a 3D Systems Company)
- Founded: 2014
- Country:
- Industry:
- Headquarters: Pennsylvania, USA
Description: Allevi, founded in 2014 and headquartered in Philadelphia, Pennsylvania, USA, is a developer of desktop 3D bioprinters, bioinks, and laboratory software for life-sciences research. In May 2021, it was acquired by 3D Systems to bolster its regenerative medicine and bioprinting capabilities.
Vision:
To lead the future of bioprinting by enabling the creation of complex biological tissues and advancing personalized medical solutions.
Mission:
To empower scientists and innovators with advanced 3D bioprinting solutions that accelerate breakthroughs in healthcare and regenerative medicine.
Contact:
- Social Media:
References:
- 3D Systems press release on acquiring Allevi in May 2021
- 3D Printing Industry coverage of acquisition and global footprint (~380 labs)
- PitchBook & Tracxn profile: founding, funding rounds, total raised, acquisition detail
- Allevi “About” page describing mission post-acquisition
- 3DPrint.com article on bioprinting strategy and broader context of ALLEVI within 3D Systems regenerative medicine mov
Investors:
Funding:
- Pre-Seed Funding: Jul 17, 2014, $: US Dollar0.05 million
- Seed Funding: Nov 1, 2014, $: US Dollar0.05 million
- Equity Crowdfunding : Jul 15, 2015, $: US Dollar0.31 million
- Seed Funding: Sep 3, 2015, $: US Dollar1.3 million
- Series A Funding: Oct 30, 2019, $: US Dollar2 million
- Initial Coin Offering : Nov 1, 2019, €1 million
Total Funding: $: US Dollar4.7 million
Key Milestones:
- 2014 : Company founded by Ricky Solorzano in Philadelphia.
- 2015–2020:: Raised approximately $3.58M over five funding rounds, notably a $1M round in October 2019; investors include 500 Global and Ben Franklin Technology Partners.
- 2018–2019: Development and market deployment of Allevi 2 and Allevi 6 models, expanding lab adoption in pharma and academic institutions (~380 labs across 40+ countries).
- May 6, 2021: Acquired by 3D Systems, integrating into its regenerative medicine and biofabrication portfolio
Products & Services:
- 3D Bioprinters: Options like the Allevi 2 and Allevi 6, capable of printing living tissue, hydrogels, collagen, PLGA, and graphene-based structures
- Bioinks and Tool Heads: Diverse biomaterials and extruder kits enable multi-material or coaxial extrusion suited to tissue fabrication and drug discovery research.
- Lab Software: Specialized applications for automating printing workflows and supporting regenerative medicine R&D.